The effect of alpha-galactosylceramide upon allogenic rejection.
Seino
K
K
Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Japan.
Yanagisawa
K
K
Taniguchi
H
H
Takada
Y
Y
Yuzawa
K
K
Otsuka
M
M
Fukao
K
K
D000818:Animals; D016026:Bone Marrow Transplantation / Q000276:immunology; D005699:Galactosylceramides / Q000494:pharmacology*; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology; D007694:Killer Cells, Natural / Q000187:drug effects* / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D013047:Specific Pathogen-Free Organisms; D023001:Transplantation Tolerance / Q000276:immunology*; D014184:Transplantation, Homologous
D005699:Galactosylceramides